Professor Wim Robberecht appointed head of University Hospitals Leuven

29/09/2018

Prof. dr. Robberecht is nieuwe CEO

As of 1 October 2018, Professor Wim Robberecht is the new chairman of the University Hospitals Leuven Management Committee. He succeeds Professor Marc Decramer, whose term ended on 30 September 2018 and who is accorded emeritus status.

Earlier this year, the University Hospitals Leuven Management Committee proposed Professor Robberecht for appointment to the Board of Governors and the Board of Trustees of KU Leuven. These Boards have given the green light and appointed Professor Robberecht for a five-year term.

Professor Luc Sels, Rector of KU Leuven: “I’m very much looking forward to a successful collaboration with Professor Robberecht. He has a lot of insight into the workings of University Hospitals Leuven and how we can further improve them. What’s more, he has a strongly developed view on the position of a university hospital in the rapidly evolving landscape of healthcare. He’s also in an excellent position to embed University Hospitals Leuven in KU Leuven even more broadly and more firmly.”

Professor Marc Decramer, current chair of the University Hospitals Leuven Management Committee: “I’m very pleased with the appointment of Wim Robberecht as the new chair. His international expertise and years of experience in the area of biomedical research and hospital management will allow him to successfully take on the many challenges of the future.”


Who is Wim Robberecht? 

Wim Robberecht (°1959) is a neurologist who specialised in ALS research. He has a PhD in biomedical sciences and has been a full professor at the KU Leuven Faculty of Medicine since 2001. From 2001 until 2013, he was head of the neurology unit at University Hospitals Leuven. In 2005, he became a member of the University Hospitals Leuven Executive Board, which he has been chairing since 2016. From 2013 until 2017, he was Vice Rector for the Biomedical Sciences Group at KU Leuven.